Verified peer comparison
J-Long Group vs PharmaCyte Biotech Financial Comparison
Direct answer
J-Long Group and PharmaCyte Biotech are compared on the same basis.
The comparison uses 2026 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free J-Long Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- J-Long Group Revenue
- 5,411,089 USD
- PharmaCyte Biotech Revenue
- 0 USD
- J-Long Group Operating income
- 378,840 USD
- PharmaCyte Biotech Operating income
- -5,304,286 USD